C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
12/2006
12/21/2006	US20060287379 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
12/21/2006	US20060287374 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/21/2006	US20060287371 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R,7S,8R,9R,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents
12/21/2006	US20060287355 Imidazo and thiazolopyridines as jak3 kinase inhibitors
12/21/2006	US20060287310 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)-butoxy]-3,4-dihydro-1H-[1,8]naphthyridin-2-one; use in the treatment of central nervous system disorders, bipolar disorder in a human; chemical synthesis
12/21/2006	US20060287309 [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
12/21/2006	US20060287308 3-Aminoquinazolin-2,4-dione antibacterial agents
12/21/2006	US20060287307 Antibacterial compounds
12/21/2006	US20060287210 can provide the combined benefits of formulation flexibility, low water temperature bleaching performance and enzyme compatibility
12/21/2006	US20060286065 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro
12/21/2006	CA2611892A1 Tetrahydroquinoline derivatives as motor protein eg5 inhibitors and antitumor agents
12/21/2006	CA2611443A1 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
12/21/2006	CA2611030A1 Alpha-(aryl-or heteroaryl-methyl)-beta-piperidinopropanoic acid compounds as orl1-receptor antagonists
12/21/2006	CA2610900A1 Compounds for the treatment of multi-drug resistant bacterial infections
12/21/2006	CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative
12/20/2006	EP1732930A2 2,4,6-phenylsubstituted cyclic ketoenoles
12/20/2006	EP1732929A1 Tricyclic benzopyran compound as anti-arrhythmic agents
12/20/2006	EP1732928A2 Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
12/20/2006	EP1732922A1 Methods for minimizing thioamide impurities
12/20/2006	EP1732921A1 Thioamide derivatives as progesterone receptor modulators
12/20/2006	EP1732903A1 Triazolone derivatives as mmp inhibitors for the treatment of asthma and copd
12/20/2006	EP1732893A2 Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
12/20/2006	EP1511732B1 Process for the manufacture of quinoline derivatives
12/20/2006	EP1305308B1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
12/20/2006	CN1882592A Manufacture of vitamin B6
12/20/2006	CN1882582A Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
12/20/2006	CN1880306A Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/20/2006	CN1880293A C2 phenyl-substituted cyclic keto-enols used as pesticides and herbicides
12/20/2006	CN1879617A Modulating multiple lineage kinase proteins
12/20/2006	CN1290849C Compound of benzopyran category marked by fluorin [*F] as well as preparation method and its application of developing agent for D4 receptor of dopamine
12/20/2006	CN1290823C Ketol fatty acid derivatives and plant growth regulators
12/20/2006	CN1290499C Usage of glanthidine, total alkali extract and preparation method and usage thereof
12/19/2006	US7151179 7-ethyl-20(S)-camptothecin; reduction and subsequent oxidation of chemical intermediates to form Irinotecan; catalysis
12/19/2006	US7151116 Apoptolidin analogs and derivatives for inducing apoptosis in transformed cells
12/19/2006	US7151108 Anticarcinogenic, antiproliferative, and antitumor agents
12/19/2006	US7151100 Indole compounds useful for the treatment of cancer
12/19/2006	US7151097 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
12/14/2006	WO2006132594A1 Novel dipodazine compounds and applications
12/14/2006	WO2006132296A1 Process for producing tricyclic ketone
12/14/2006	WO2006132192A1 Novel 2-quinolone derivative
12/14/2006	WO2006105291A3 Heterocyclical chromophore architectures with novel electronic acceptor systems
12/14/2006	WO2006082409A3 Tricyclic cytoprotective compounds
12/14/2006	WO2006081289A3 Antibacterial agents
12/14/2006	US20060281776 Isotope labeled camptothecin derivatives
12/14/2006	US20060281746 neurokinin receptor 3 (NK3) antagonists; psychological disorders, inflammatory bowel disease, asthma, ischemia, Parkinson's disease; e.g. (1S,2R)-2-(4-Acetylamino-4-phenyl-piperidin-1-ylmethyl)-1-(3,4-dichlorophenyl)-cyclopropanecarboxylic acid, benzyl-methyl-amide
12/14/2006	US20060281730 beta secretase inhibitors, used to treat cardiovascular diseases, cognitive and neurodegenerative diseases
12/14/2006	US20060281629 Catalyzing the oxidation, carbonylation, nitration, sulfonation reaction; catalyst selectivity; produce terephthalic acid from p-xylene or from p-toluic acid; produce pyromellitic acid from durene
12/14/2006	DE102005027170A1 New substituted tetrahydroquinoline compounds are mitotic motor-protein Eg5 modulators useful to treat or prevent e.g. cancer, glioblastoma, lymphatic leukemia, arteriosclerosis, eye disease, diabetic retinopathy and arthritis
12/14/2006	CA2611312A1 Organic compounds
12/13/2006	EP1731508A1 Weakly basic hindered amines having carbonate skeletons, synthetic resin compositions, and coating compositions
12/13/2006	EP1730165A1 Inhibitors of hepatitis c virus ns3 protease
12/13/2006	EP1730154A2 Rifamycin derivatives effective against drug-resistant microbes
12/13/2006	EP1730152A2 Tetrahydroquinoline derivatives and a process for preparing the same
12/13/2006	EP1730145A1 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
12/13/2006	EP1730140A1 Opioid receptor antagonists
12/13/2006	EP1730110A1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
12/13/2006	CN1878775A Novel chelidonine derivatives, methods for the production thereof, and use thereof for producing pharmaceutical agents
12/13/2006	CN1878758A Crf antagonists and heterobicyclic compounds
12/13/2006	CN1878756A Sulfonyltetrahydro-3H-benzo(E)indole-8-amine compounds as 5-hydroxytryptamine-6 ligands
12/13/2006	CN1876634A Sinomenine structure-modified compound and its preparation method
12/13/2006	CN1289502C New derivatives of benzo[a]pyrano[3,2-h]acridin-7-one, a process for their preparation and pharmaceutical compounds containing them
12/13/2006	CN1289501C Fused heterotricyclic compound, process for preparing compounds and drugs containing the same
12/12/2006	US7148347 Reacting macrocyclic amide compound with hydroxy naphthalene or hydroxy quinoline derivative in a polar non-protic organic solvent in the presence of an organic or inorganic base
12/12/2006	US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
12/12/2006	US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
12/12/2006	US7148233 Treatment of cardiovascular and related pathologies
12/12/2006	CA2266081C Process for producing ecteinascidin compounds
12/12/2006	CA2153570C Pharmaceutical composition for treating nicotine dependence
12/12/2006	CA2147608C Topoisomerase ii inhibitors and therapeutic uses therefor
12/07/2006	WO2006130673A1 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
12/07/2006	WO2006129826A1 Novel piperidine derivative
12/07/2006	WO2006129524A1 Carbonyl compound remover
12/07/2006	WO2006128852A2 Heterocyclic spiro-compounds as aldosterone synthase inhibitors
12/07/2006	WO2006128851A1 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors
12/07/2006	WO2006128268A1 Ureidic compounds, pharmaceutical compositions containing the same and their use on the treatment of inflammatory diseases
12/07/2006	WO2005067546A3 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases
12/07/2006	US20060276645 Novel carboxylic acid derivatives, their preparation and use
12/07/2006	US20060276499 Imidazopyridine intermediates
12/07/2006	US20060276497 Novel multicyclic compounds and the use thereof
12/07/2006	US20060276481 Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
12/07/2006	US20060276474 Novel carboxylic acid derivatives, their preparation and use
12/07/2006	US20060276466 Bicyclic heterocycles as HIV integrase inhibitors
12/07/2006	US20060276463 Pure levofloxacin hemihydrate and processes for preparation thereof
12/07/2006	US20060276450 Isoquinoline potassium channel inhibitors
12/07/2006	DE102005025625A1 New benzazecine derivatives are dopamine receptor antagonists useful to treat schizophrenia
12/07/2006	CA2609930A1 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors
12/07/2006	CA2609660A1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors
12/07/2006	CA2609388A1 Novel piperidine derivative
12/07/2006	CA2575045A1 Furanopyridine derivatives and methods of use
12/06/2006	EP1727817A1 Azabicyclooctan-3-one derivatives and use thereof
12/06/2006	EP1270577B1 Furoisoquinoline derivatives, process for producing the same and use thereof
12/06/2006	EP1137411B1 Palladium-substituted bacteriochlorophyll derivatives and use thereof
12/06/2006	CN1875022A Tocopherol-modified therapeutic drug compounds
12/06/2006	CN1875020A Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
12/06/2006	CN1875004A Resolution of a narwedine amide derivative
12/06/2006	CN1874997A 2-halogen-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives
12/06/2006	CN1872859A Compound of heterocyclic pyridine class
12/06/2006	CN1288158C Therapeutic or preventive agent for nausea/vomiting
12/06/2006	CN1288157C Dioxadiene pyridine compounds for treating impaired fundic relaxation, method of preparation and use thereof
12/06/2006	CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists

1 ... 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 ... 298